Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

cyclopia sequence 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Tuberous Sclerosis 1 Sezary Syndrome 1 Seizures 1 Prostatic Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lung Neoplasms 1 Lennox Gastaut Syndrome 1 Epilepsy 1 Epilepsies, Myoclonic 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Cancers 1 Adenomatous Polyposis Coli 1

Interventions

Radiotherapy 9 Cisplatin 9 Paclitaxel 6 Carboplatin 6 Radiation 3 Biopsy 3 Bevacizumab 3 balstilimab 2 Topotecan 2 Taxes 2 Nivolumab 2 Ipilimumab 2 Gemcitabine 2 Colposcopy 2 Brachytherapy 2 tislelizumab 1 spartalizumab 1 sitravatinib 1 rucaparib 1 pazopanib 1 infigratinib 1 fludarabine 1 bemarituzumab 1 atezolizumab 1 aldesleukin 1 Watchful Waiting 1 Vinorelbine 1 Vaginal Smears 1 Ultrasonography 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Uterine Cervical Neoplasms × Curcumin × Clear all

NCT04294836 2022-12-07

Curcumin in Advanced Cervical Cancer

Instituto Nacional de Cancerologia, Columbia

Phase 2 Withdrawn

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡